"Designing Growth Strategies is in our DNA"
The global PET scanners market size was valued at USD 2.83 billion in 2025 and is projected to grow from USD 2.96 billion in 2026 to USD 4.37 billion by 2034, exhibiting a CAGR of 5.0% during the forecast period.
PET scanners are medical imaging devices that produce 3D images of metabolic, functional, and chemical activity inside the body. The growing prevalence of chronic disorders, increasing diagnostic procedure volumes, growing early detection of diseases, and the development of healthcare infrastructure are resulting in a rising adoption rate of these systems in the market. The growing aging population is further supporting the demand for innovative medical imaging devices in the market.
Additionally, the increasing incorporation of technological advancements in these devices among the major players, such as GE Healthcare and Siemens Healthineers AG, among others, is further contributing to the demand for these devices in the market.
Increasing Demand for Technological Advancements in Products to Fuel Demand
There is an increasing demand for technologically advanced products of higher strengths, including PET/CT, PET/MRI, among others. Traditional scanning has been using standalone PET scanners; however, with the advent of technology, hybrid models are being utilized across healthcare settings.
The integration of these imaging technologies is crucial in the diagnosis of chronic disorders, including heart diseases, neurological disorders, and others. The growing technological advancements in these devices provide accuracy and resolution, minimizing the scanning time, and enhancing patient outcomes by producing high-quality images among the patient population.
Download Free sample to learn more about this report.
Increasing Prevalence of Chronic Disorders to Fuel Market Growth
The rising prevalence of chronic conditions, such as cardiovascular disorders, cancer, among others, is anticipated to increase the diagnosis and treatment rate among patients globally. The growing aging population is another crucial factor resulting in the rising patient population suffering from these disorders.
This, coupled with rising technological advancements in the products and improving healthcare access, is further supporting the adoption rate of these devices in the market. Therefore, the factors above, coupled with the growing focus of key players on introducing research and development activities to launch innovative products, are anticipated to boost the adoption rate of these devices, thereby supporting the global market size.
High Cost Associated with these Devices to Hamper Market Growth
There is a growing demand for imaging medical devices, including PET/CT scanners, PET/MRI scanners, and others in healthcare facilities. However, one of the crucial factors that hampers the adoption of these systems is the high cost associated with these devices. The upfront cost associated with the purchase and implementation of imaging devices is very high, owing to the addition of developing costs, distributors’ margins, and service costs.
Additionally, the growing advancements in these devices among the major players are resulting in growing prices, further making it challenging for small hospitals and clinics to adopt these devices, thereby hindering the market growth significantly, particularly in the emerging countries.
Expansion of Applications for PET Scanners to Create an Opportunity
There is an increasing acceptance of these products in several fields of medicine. A growing number of medical specialists are adopting these systems due to the diverse range of medical applications associated with these devices. According to several studies, molecular imaging, which includes PET scanners, offers the ability to accurately diagnose the biological response to disease treatment in individual patients over time.
Furthermore, imaging procedures are becoming much faster due to the adoption of advanced technology in these systems. Molecular Point-Of-Care (POC) enables more accurate and faster diagnosis by providing quick detection and infection control among the patient population.
Limited Diagnostic Centers in Developing Countries to Hinder Market Growth
There is a growing demand for diagnostic procedures among the patient population. However, limited availability of technologically advanced products, limited healthcare expenditure, coupled with an inadequate reimbursement framework, especially in emerging countries, are resulting in limited access to healthcare facilities among the patient population.
Additionally, a limited number of clinical facilities and limited professionals, among others, are some of the crucial factors, resulting in the delayed diagnostic procedures among the patient population, particularly in emerging countries, including Brazil, China, among others.
Increasing Number of Product Launches Led to PET/CT Segmental Dominance
Based on the product type, the market is classified into standalone PET scanners, PET/CT, and PET/MRI.
The PET/CT segment held the largest revenue share in 2025. The growth is due to the growing prevalence of chronic conditions among the patient population, resulting in an increasing number of diagnostic procedures globally. This, along with the rising emphasis of key players on launching novel products, is further expected to contribute to the global PET scanners market growth.
The PET/MRI segment is expected to grow at a CAGR of 5.2% over the forecast period.
To know how our report can help streamline your business, Speak to Analyst
Growing Product Launches Led to Dominance of Fixed Segment
Based on mobility, the market is segmented into fixed and portable.
The fixed segment dominated the global market in 2025. By mobility, the fixed segment held the share of 93.1% in 2025. The growth is due to the growing prevalence of chronic conditions such as cancer and others, resulting in a rising demand for fixed products, thereby contributing to the adoption rate of these products in the market.
The segment of portable is set to flourish with a growth rate of 5.9% across the forecast period.
Growing Prevalence of Cancer Led to Dominance of Segment
Based on application, the market is segmented into cardiology, oncology, orthopedics, gynecology, neurology, and others.
The oncology segment dominated the global market in 2025. By application, the oncology segment accounted for 71.4% in 2025. The growth is due to the increasing prevalence of chronic conditions, including various types of cancer, among others, resulting in a growing number of diagnostic procedures globally, thereby contributing to the adoption rate of these devices in the market.
The segment of neurology is set to flourish with a growth rate of 6.5% across the forecast period.
Increasing Number of Hospitals Led to Segmental Dominance
Based on end user, the market is segmented into hospitals, specialty clinics, diagnostic imaging centers, and others.
The hospitals segment dominated the market in 2025. The increasing prevalence of chronic disorders, rising number of diagnostic procedures in hospitals, increasing number of healthcare settings, such as hospitals, among others, are some of the crucial factors contributing to the growth of the segment in the market. Furthermore, the segment is set to hold a 61.3% share in 2026.
In addition, diagnostic imaging centers’ end users are projected to grow at a 5.4% CAGR during the forecast period.
Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America PET Scanners Market Size, 2025 (USD Billion)
To get more information on the regional analysis of this market, Download Free sample
The North America market held the dominant share in 2024, valued at USD 1.05 billion, and also took the leading share in 2025 with USD 1.08 billion. The increasing prevalence of chronic disorders, high healthcare spending, and adoption of advanced imaging, among others, are some of the factors contributing to the growth of the segment in the market.
Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 1.04 billion in 2026, accounting for roughly 35.0% of global sales.
Europe is projected to record a growth rate of 3.6% in the coming years, which is the second highest among all regions, and reach a valuation of USD 0.81 billion by 2026. The strong installed base and increasing theranostics programs in major European countries are anticipated to support the market growth.
The U.K. market in 2026 is estimated at around USD 0.14 billion, representing roughly 4.7% of global revenues.
Germany’s market size is projected to reach approximately USD 0.18 billion in 2026, equivalent to around 6.2% of global sales.
The Asia Pacific market is estimated to reach USD 0.73 billion in 2026 and secure the position of the third-largest region. The fastest installation growth is driven by China, Japan, and India’s expanding oncology imaging infrastructure and adoption of advanced diagnostics, further anticipated to support the development of the market. In the region, India and China are both estimated to reach USD 0.10 billion and USD 0.30 billion, respectively, in 2026.
The Japan market in 2026 is estimated at around USD 0.20 billion, accounting for roughly 6.6% of global revenues. Japan has historically reported a relatively high prevalence of various types of cancer, with a growing number of such scans among the patient population.
China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 0.30 billion, representing roughly 10.0% of global sales.
The Indian market size in 2026 is estimated at around USD 0.10 billion, accounting for roughly 3.2% of global revenues.
Latin America and the Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 0.17 billion in 2026. The growth is due to growing installations for such scanners across healthcare settings. The Middle East & Africa are also anticipated to grow due to increasing medical tourism and rising healthcare access in the region. In the Middle East & Africa, the GCC is set to reach a value of USD 0.06 billion in 2026.
The South Africa market is projected to reach around USD 0.03 billion in 2026, representing roughly 1.1% of global revenues.
Rising Strategic Initiatives Among Key Players to Support Market Dominance of these Companies
A strong device portfolio and continuous focus on strategic initiatives globally are key factors supporting the leadership of major companies. In 2025, leading players such as GE Healthcare and Siemens Healthineers AG hold a significant position in the market. Additionally, the increasing emphasis on inorganic growth strategies by key companies to expand the production capacity is expected to further strengthen their global PET scanners market share.
Other prominent companies, including Koninklijke Philips N.V., and others, are also expanding their presence in the market. Their growth is mainly driven by increased investments in research and development activities aimed at introducing new advanced devices among other players and strengthening their competitive market position.
The report provides a detailed global PET scanners market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, mobility, application, and end user. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.
Request for Customization to gain extensive market insights.
| ATTRIBUTE | DETAILS |
| Study Period | 2021-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2021-2024 |
| Growth Rate | CAGR of 5.0% from 2026-2034 |
| Unit | Value (USD Billion) |
| Segmentation | By Product Type, Mobility, Application, End User, and Region |
| By Product Type |
|
| By Mobility |
|
| By Application |
|
| By End User |
|
| By Region |
|
Fortune Business Insights says that the global market size was USD 2.83 billion in 2025 and is projected to reach USD 4.37 billion by 2034.
In 2025, the market value stood at USD 1.08 billion.
Growing at a CAGR of 5.0%, the market will exhibit steady growth over the forecast period.
By product type, the PET/CT segment is the leading segment in this market.
The introduction of innovative PET scanners is one of the major factors driving the markets growth.
GE Healthcare and Siemens Healthineers AG are the major players in the global market.
North America dominated the market share in 2025.
The growing prevalence of chronic disorders, the increasing number of diagnostic procedures, among others, are some of the crucial factors anticipated to boost the adoption of these products globally.
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )